$79.95
0.25%
NYSE, Jan 02, 10:00 pm CET

Haemonetics Corporation Stock price

$79.98
-0.81 1.00% 1M
+3.74 4.91% 6M
-0.17 0.21% YTD
+1.58 2.02% 1Y
+1.33 1.69% 3Y
-39.09 32.83% 5Y
+48.73 155.94% 10Y
+55.55 227.38% 20Y
NYSE, Closing price Fri, Jan 02 2026
-0.17 0.21%

Key metrics

Basic
Market capitalization
$3.7b
Enterprise Value
$4.7b
Net debt
$928.3m
Cash
$296.4m
Shares outstanding
46.8m
Valuation (TTM | estimate)
P/E
22.7 | 16.1
P/S
2.8 | 2.8
EV/Sales
3.5 | 3.5
EV/FCF
22.0
P/B
4.4
Financial Health
Equity Ratio
33.5%
Return on Equity
20.4%
ROCE
13.4%
ROIC
10.1%
Debt/Equity
1.4
Financials (TTM | estimate)
Revenue
$1.3b | $1.3b
EBITDA
$299.9m | $441.6m
EBIT
$253.8m | $348.3m
Net Income
$168.2m | $232.0m
Free Cash Flow
$212.6m
Growth (TTM | estimate)
Revenue
-2.5% | -2.2%
EBITDA
16.6% | 50.5%
EBIT
18.0% | 42.0%
Net Income
35.8% | 38.4%
Free Cash Flow
583.3%
Margin (TTM | estimate)
Gross
58.5%
EBITDA
22.6% | 33.2%
EBIT
19.1%
Net
12.7% | 17.4%
Free Cash Flow
16.0%
More
EPS
$3.5
FCF per Share
$4.5
Short interest
9.7%
Employees
4k
Rev per Employee
$370.0k
Show more

Is Haemonetics Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Haemonetics Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Haemonetics Corporation forecast:

12x Buy
80%
3x Hold
20%

Analyst Opinions

15 Analysts have issued a Haemonetics Corporation forecast:

Buy
80%
Hold
20%

Financial data from Haemonetics Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,328 1,328
2% 2%
100%
- Direct Costs 552 552
12% 12%
42%
776 776
6% 6%
58%
- Selling and Administrative Expenses 411 411
2% 2%
31%
- Research and Development Expense 63 63
6% 6%
5%
300 300
17% 17%
23%
- Depreciation and Amortization 46 46
10% 10%
3%
EBIT (Operating Income) EBIT 254 254
18% 18%
19%
Net Profit 168 168
36% 36%
13%

In millions USD.

Don't miss a Thing! We will send you all news about Haemonetics Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Haemonetics Corporation Stock News

Neutral
PRNewsWire
one day ago
BOSTON, Jan. 2, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 7:30 am Pacific Time.
Positive
Forbes
4 days ago
Currently priced at approximately $80.53 per share, Haemonetics (NYSE: HAE) is trading roughly 7.6% below its 52-week high.
Negative
Seeking Alpha
about one month ago
The Touchstone Small Company Fund underperformed its benchmark, the Russell 2000 Index, for the quarter ended September 30, 2025. Among the Fund's top-performing sectors in terms of adding value were Financials and Consumer Staples. From a factor perspective, the Fund's focus on profitable, liquid, and higher quality small cap stocks negatively impacted relative performance during the quarter.
More Haemonetics Corporation News

Company Profile

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.

Head office United States
CEO Christopher Simon
Employees 3,657
Founded 1971
Website www.haemonetics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today